Searchable abstracts of presentations at key conferences in endocrinology

ea0099p38 | Calcium and Bone | ECE2024

Hypoparathyroidism following thyroid surgery: Risk factors and the role of early postsurgical PTH determination

Matos Tania , Dias Daniela , Silvestre Catarina , Serra Filipa , Marques Pedro , Leichsenring Carlos , Pinheiro Nuno , Sapinho Ines

Introduction: Hypoparathyroidism is one of the most common complications following thyroidectomy and it is associated with significant morbidity. It usually occurs within the first 48 h after thyroid surgery, however hypocalcemia symptoms may only begin up to 64 h after surgery. Therefore, early detection of hypoparathyroidism is essential to a secure postsurgery discharge.Objectives: We aimed to evaluate the potential risk factors for postsurgical hypop...

ea0099ep76 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Complications and metabolic control in adults with diabetes aged 16-25 years old

Leitao Francisca , Zambre Sae , Du Lucy , Carlos Cordeiro Maria , Quitalo Ana

Introduction: Diabetes mellitus (DM) is a chronic disease with increasing incidence worldwide, mostly in younger ages. Diabetic kidney disease (DKD) is a main complication, with a prevalence of 20-40%, associated with high cardiovascular mortality. Despite the association of type 2 diabetes (T2D) in young adults with rapid progression to DKD, in type 1 diabetes (T1D) this is not well established. Other complications have also a high impact on life quality.<p class="abstext...

ea0099ep444 | Pituitary and Neuroendocrinology | ECE2024

Utility of the Metoclopramide Test in the Differential Diagnosis of Hyperprolactinaemia

Chaieb Estibaliz Alegre Chadli , Gonzalez Alvaro , Zaballos Marta , Casal Henar , Salvador Javier , Carlos Galofre Juan

Introduction: In addition to physiological causes, the hyperprolactinemia spectrum includes iatrogenesis, pituitary adenomas, various diseases and functional disorders. Hyperprolactinemia accurate etiological diagnosis is essential for appropriate treatment. Non-functioning pituitary incidentalomas occur in approximately 10% of the population and tiny microprolactinomas could be elusive to imaging by magnetic resonance (MRI). Therefore, the coincidence of hyperprolactinemia an...

ea0099ep891 | Pituitary and Neuroendocrinology | ECE2024

Mucocutaneous diathesis in severe cushing disease

Redondo de Carvalho Ines , Carda Jose , Tavares Bello Carlos , Esperanca Isabel , Sobral do Rosario Francisco

Introduction: Cushing syndrome is a complex disease with multisystemic manifestations. It includes skin and connective tissue abnormalities, in which glucocorticoids reduce the synthesis and production of collagen, resulting in skin thinning, subcutaneous vascular tissue frailty and mucocutaneous bleeding. Case report: A 59-year-old woman with history of hypertension, type 2 diabetes, hypercholesterolemia, and chronic kidney disease, was admitted to the ...

ea0099ep137 | Thyroid | ECE2024

Thyroid pathology in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Ernaga Ander , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...

ea0099ep838 | Thyroid | ECE2024

Intra-Thyroid metastases of clear cell renal carcinoma - analysis of two complex cases

Ribeiro Sara , Goncalves Juliana , Carlos Almeida Joao , Varela Ana , Queiros Joana

Introduction: Intra-thyroid metastases are infrequent, comprising only 1-3% of all thyroid malignancies. Renal cell carcinoma, particularly of the clear cell type (CCRC), stands out as the predominant kidney malignancy and the most common primary source of intra-thyroid metastases, often manifesting several years post-diagnosis. This report highlights two cases of CCRC metastasis to the thyroid, both featuring deceptive cytological findings.Case 1: A 60-...

ea0101ps2-17-01 | Non-surgical treatment | ETA2024

Predictive factors for success of radioactive iodine treatment in graves’ disease

Quitalo Ana , Henriques Francisca , Franco Sara , Barbosa David , Manuel Costa Maria , Carlos Cordeiro Maria , Raimundo Luisa

Objectives: Correction of 131I dose for thyroid gland size is one of the methods used to determine radioactive iodine (RAI) activity for patients with Graves’ disease (GD), but the predictive factors for its clinical outcome are still unclear. This study aimed to investigate which factors influence its success in a real-world cohort.Methods: Observational and retrospective study of RAI treatments in a terciary referral center in Almada, Portugal, ca...

ea0101ps2-17-02 | Non-surgical treatment | ETA2024

Efficacy of radioactive iodine treatment in graves’ disease using a calculated 131i dose in a portuguese cohort

Henriques Francisca , Quitalo Ana , Franco Sara , Barbosa David , Manuel Costa Maria , Carlos Cordeiro Maria , Raimundo Luisa

Objective: To evaluate the success of administration of 131Iodine adjusted for thyroid gland size in the treatment of hyperthyroidism in Graves’ disease.Methods: All patients with Gravés hyperthyroidism who underwent therapeutic administration of 131I in a referral center in Portugal, from 2014 to 2022 were selected. Values of estimated thyroid gland size, administrated doses of 131I and 24h radioactive iodine u...

ea0090ep437 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Real-world effectiveness analysis of oral versus subcutaneous semaglutide in patients with type 2 diabetes mellitus

Ferrer Garcia Juan Carlos , Albalat-Galera Raquel , Moya Victor Atienza , Hernandez Jessica Sanchez , Palomar Luis Arribas , Casamayor Ignacio Ramos , Fullana Ana Artero , Blanco Cintia Gonzalez , Portilla Ana Jimenez , Juan Carlos Sanchez

Background and Objective: Semaglutide, a glucagon-like peptide 1 (GLP1a) receptor agonist, reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus (DM2). An oral version of semaglutide is now available, and patients may prefer it to the subcutaneous form. Our objective was to compare the effectiveness and safety of both formulations in real life.Methods: Retrospective real-world efficacy analysis including aGLP1-...

ea0049oc5.1 | Cardiovascular Endocrinology | ECE2017

Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes

Barros Eric , Ortiz David , Campino Carmen , Valdivia Carolina , Tapia-Castillo Alejandra , Lizama Jaime , Allende Fidel , Solari Sandra , Gonzalez Jose Vicente , Martinez-Aguayo Alejandro , Vecchiola Andrea , Repetto Gabriela , Aglony Marlene , Baudrand Rene , Salomon Carlos F , Fardella Carlos E , Carvajal Cristian

Arterial hypertension is a major health problem affecting 1.13 billion people worldwide, of which 10% could be due to endocrine pathologies related to the mineralocorticoid receptor (MR) (i.e. primary aldosteronism, 11β-hydroxysteroid dehydrogenase type 2 enzyme (HSD11B2) deficiency). The MR pathway is expressed mainly in placenta, kidney and colon epithelial cells. Current research highlights potential epigenetic regulatory mechanisms for the MR pathway. Here, specific m...